Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“Closing J.P. Morgan with our AI Partnership Expedition
One of the highlights of the week was spending focused time in Mountain View with our partners at Google and Microsoft, deepening the collaboration that fuels our AI ambitions at Servier. These conversations — with tech leaders, VCs, and breakthrough entrepreneurs — were both inspiring and grounding.
Our strategic partnerships — across big tech and med‑tech leaders like OWKIN, Aitia, Insilico Medicine, and iktos — are already accelerating the way we understand diseases, discover new therapies, with the goal of bringing transformative therapies to cancer patients.
This week reinforced my excitement about the future of AI and its impact on R&D. Excited to carry this momentum into 2026 and turn these connections into tangible progress.”
More posts featuring Walid Kamoun.
